Roche Showcases the Future of Diagnostic Solutions at EUROMEDLAB 2022

Roche Diagnostics (Basel, Switzerland) showcased its next generation diagnostics solutions that deliver fast and accurate results to help clinicians improve patient care and help reduce the healthcare burden at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines (EUROMEDLAB) in Munich, Germany.

These included the cobas 5800 System that expands access to PCR testing with meaningful and timely results to more patients across the globe, and a new handheld glucose management device, the cobas pulse, powered by the cobas infinity edge suite, that equips healthcare professionals with expanded digital capabilities at the point of care. An evaluation of the recently launched AVENIO Tumour Tissue Comprehensive Genomic Profiling (CGP) Kit for oncology research was also presented. The kit helps expand access to genomic profiling globally, supporting researchers in navigating the complex landscape of cancer research. The findings assess genomic results generated across multiple CGP workflows for variants that are known to cause and drive cancer.

Roche also hosted its very own highly interactive booth, where attendees visited and experienced how the company is helping to improve healthcare. Highlights from the booth included an integrated diagnostics lab and data analytics tools that guide the decision-making process toward optimizing lab operations, customer delivery, and overall lab performance in a targeted and efficient manner. There was also a special interactive area at the booth highlighting Roche’s COVID-19 response. Those unable to attend the congress in person were able to view and engage in the virtual booth via an online portal, with Ro_Bot, a virtual character, as host: Roche EUROMEDLAB 2021. Those joining online were able to follow key sessions via livestream, at no cost. During the congress, Roche also facilitated discussions on key topics in diagnostics today, including three educational workshops.

“Roche is committed to developing innovative solutions that equip healthcare professionals with the tools that allow for earlier diagnosis and more personalized treatment, optimizing patient care and leading to better outcomes,” said Ann Costello, Global Head, Roche Diagnostics Solutions. “We are proud to work in partnership with healthcare professionals across many disease areas and disciplines to enable better healthcare decisions.”

“Lab medicine has always played a key role in healthcare, as proven during the Covid-19 pandemic,” added Moritz Hartmann, Global Head of Roche Information Solutions. “We are working with industry leaders worldwide on digital health solutions to facilitate data-driven decision-making in any setting. This includes labs, clinics and homes with the ultimate goal to improve care for each patient and reduce inefficiencies in healthcare delivery.”

Related Links:
Roche Diagnostics 

Visit expo >

New

Gold Member

C-Reactive Protein Reagent

CRP Ultra Wide Range Reagent Kit

Antipsychotic TDM AssaysSaladax Antipsychotic Assays

New

Urine cfDNA Extraction Kit

CloNext Urine cfDNA Extraction Kit

New

Rocking Shaker

HumaRock